U.S. E-prescribing Market Size & Outlook, 2023-2030
U.S. e-prescribing market, 2018-2030 (US$M)
Related Markets
U.S. e-prescribing market highlights
- The U.S. e-prescribing market generated a revenue of USD 1,455.9 million in 2023 and is expected to reach USD 6,878.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 24.8% from 2024 to 2030.
- In terms of segment, solution was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
E-prescribing market data book summary
| Market revenue in 2023 | USD 1,455.9 million |
| Market revenue in 2030 | USD 6,878.6 million |
| Growth rate | 24.8% (CAGR from 2023 to 2030) |
| Largest segment | Solution |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Solution, Services |
| Key market players worldwide | Oracle Corp, Allscripts Healthcare, Epic Systems Corporation, Athenahealth, NXGN, McKesson Corp, UnitedHealth Group Inc, DrFirst, Surescripts, Veradigm Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 39.7% of the global e-prescribing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. e-prescribing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 920.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
E-Prescribing Market Scope
E-Prescribing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. e-prescribing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to e-prescribing market will help companies and investors design strategic landscapes.
Solution was the largest segment with a revenue share of 58.72% in 2023. Horizon Databook has segmented the U.S. e-prescribing market based on solution, services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the most mature e-prescribing market, which can be attributed to the fact that the country has advanced infrastructure and high focus on R&D. Over the forecast period the market is anticipated to witness steady growth.
Increasing opioid crisis in the country is driving development in e-prescribing technology. Electronic Prescription in Controlled Substances (EPCS) provides a transparent, secure system that makes it relatively easier to prescribe numerous controlled substances to patients who need them, at the same time, making it challenging to commit fraud or abuse.
Moreover, companies are taking initiatives for advancing and innovating the e-prescribing system. For instance, in January 2019, Veradigm, a subsidiary of Allscript, partnered with Microsoft to establish a cloud-based electronic health record.
Reasons to subscribe to U.S. e-prescribing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. e-prescribing market databook
-
Our clientele includes a mix of e-prescribing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. e-prescribing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. e-prescribing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. e-prescribing market size, by product, 2018-2030 (US$M)
U.S. E-Prescribing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
